These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 16627307

  • 1. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
    Bell J, Mutch C.
    Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
    [Abstract] [Full Text] [Related]

  • 2. Retention and attendance with supervised buprenorphine treatment: a case-note review.
    Bell J, Burrell T.
    Drug Alcohol Rev; 2006 Mar; 25(2):161-5. PubMed ID: 16627306
    [Abstract] [Full Text] [Related]

  • 3. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J, Trinh L, Butler B, Randall D, Rubin G.
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [Abstract] [Full Text] [Related]

  • 4. [Buprenorphine and methadone to opiate addicts--a randomized trial].
    Kristensen Ø, Espegren O, Asland R, Jakobsen E, Lie Ø, Seiler S.
    Tidsskr Nor Laegeforen; 2005 Jan 20; 125(2):148-51. PubMed ID: 15665884
    [Abstract] [Full Text] [Related]

  • 5. Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.
    Burns L, Randall D, Hall WD, Law M, Butler T, Bell J, Degenhardt L.
    Addiction; 2009 Aug 20; 104(8):1363-72. PubMed ID: 19549053
    [Abstract] [Full Text] [Related]

  • 6. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.
    Addiction; 2007 Apr 20; 102(4):616-22. PubMed ID: 17286641
    [Abstract] [Full Text] [Related]

  • 7. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
    Blondell RD, Smith SJ, Servoss TJ, DeVaul SK, Simons RL.
    J Addict Dis; 2007 Apr 20; 26(2):3-11. PubMed ID: 17594993
    [Abstract] [Full Text] [Related]

  • 8. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.
    Bell J, Burrell T, Indig D, Gilmour S.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):55-61. PubMed ID: 15993552
    [Abstract] [Full Text] [Related]

  • 9. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.
    Pharmacopsychiatry; 2002 Sep 04; 35(5):159-64. PubMed ID: 12237786
    [Abstract] [Full Text] [Related]

  • 10. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA.
    Drug Alcohol Depend; 2005 Jul 04; 79(1):113-6. PubMed ID: 15943950
    [Abstract] [Full Text] [Related]

  • 11. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A, Henrion R, Lowenstein W, Charpak Y.
    Ann Med Interne (Paris); 2001 Apr 04; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [Abstract] [Full Text] [Related]

  • 12. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S.
    Addiction; 2008 Mar 04; 103(3):462-8. PubMed ID: 18190664
    [Abstract] [Full Text] [Related]

  • 13. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG.
    Addiction; 2009 Jun 04; 104(6):982-92. PubMed ID: 19466922
    [Abstract] [Full Text] [Related]

  • 14. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Jun 04; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 15. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J, Metzner C, Paetzold W, Borsutzky M, Ohlmeier M, Passie T, Hauser U, Becker H, Wiese B, Emrich H, Schneider U.
    Addict Biol; 2005 Jun 04; 10(2):157-64. PubMed ID: 16191668
    [Abstract] [Full Text] [Related]

  • 16. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):9-15. PubMed ID: 19608355
    [Abstract] [Full Text] [Related]

  • 17. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
    Winstock AR, Lea T, Sheridan J.
    Drug Alcohol Rev; 2008 Jul 01; 27(4):393-7. PubMed ID: 18584389
    [Abstract] [Full Text] [Related]

  • 18. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM, Grinshpoon A.
    Am J Drug Alcohol Abuse; 2007 Jul 01; 33(5):631-42. PubMed ID: 17891656
    [Abstract] [Full Text] [Related]

  • 19. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.
    J Subst Abuse Treat; 2007 Jul 01; 33(1):85-90. PubMed ID: 17588493
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.
    Addiction; 2009 Jun 01; 104(6):993-9. PubMed ID: 19392907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.